Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-25-034601
Filing Date
2025-03-06
Accepted
2025-03-06 16:05:34
Documents
98
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K eypt-20241231.htm   iXBRL 10-K 3561601
2 EX-10.11 eypt-ex10_11.htm EX-10.11 158994
3 EX-19.1 eypt-ex19_1.htm EX-19.1 95720
4 EX-21.1 eypt-ex21_1.htm EX-21.1 7907
5 EX-23.1 eypt-ex23_1.htm EX-23.1 3905
6 EX-31.1 eypt-ex31_1.htm EX-31.1 13759
7 EX-31.2 eypt-ex31_2.htm EX-31.2 13833
8 EX-32.1 eypt-ex32_1.htm EX-32.1 6454
9 EX-32.2 eypt-ex32_2.htm EX-32.2 6545
10 EX-97.1 eypt-ex97_1.htm EX-97.1 75484
  Complete submission text file 0000950170-25-034601.txt   13617402

Data Files

Seq Description Document Type Size
11 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT eypt-20241231.xsd EX-101.SCH 1854916
101 EXTRACTED XBRL INSTANCE DOCUMENT eypt-20241231_htm.xml XML 2282369
Mailing Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472
Business Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472 617-926-5000
EyePoint Pharmaceuticals, Inc. (Filer) CIK: 0001314102 (see all company filings)

EIN.: 262774444 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-51122 | Film No.: 25715198
SIC: 3826 Laboratory Analytical Instruments
(CF Office: 08 Industrial Applications and Services)